*Achromobacter* spp. are nonfermenting Gram-negative bacilli considered as emerging pathogens in cystic fibrosis (CF) patients [@bib1], [@bib2]. Since the description of the type species, *A. xylosoxidans* [@bib3], 14 other species have been ranked into the genus *Achromobacter: A. piechaudii* and *A. ruhlandii* [@bib4], *A. denitrificans* [@bib5], *A. spanius* and *A. insolitus* [@bib6], *A. marplatensis* [@bib7], *A. animicus, A. mucicolens, A. pulmonis* and *A. spiritinus* [@bib8], *A. insuavis, A. aegrifaciens, A. anxifer* and *A. dolens* [@bib9], and 6 other genogroups. These 21 species and genogroups can be distinguished by the multilocus sequence typing (MLST) scheme proposed by Spilker *et al.* [@bib10]. The study demonstrated that sequencing a 765 bp internal fragment of the only *nrdA* gene is sufficient for correct identification [@bib11]. Because of the actual difficulty in performing accurate species identification, most isolates are still referred by default as *A. xylosoxidans,* preventing the evaluation of the real epidemiology and clinical impact of each species. Moreover, the data about the mechanisms of innate antibiotic resistance are scarce [@bib12], [@bib13]. The AxyXY-OprZ RND efflux system confers resistance to aminoglycosides (AG) in *A. xylosoxidans* AXX-A since reclassified as *A. insuavis* (accession number [AFRQ01000000](http://AFRQ01000000){#intref0010}). Nevertheless, AG, which take an important part in CF antimicrobial therapy, remain active against some isolates of *Achromobacter* spp. [@bib14], [@bib15].

We sought to describe the distribution of AG-resistant isolates among the different species of the genus *Achromobacter* and to search for the *axyXY-oprZ* efflux operon in AG-resistant and -susceptible isolates to assess if AG resistance is correlated with the presence of the operon.

Forty-nine *Achromobacter* isolates harbouring various AG resistance patterns were included in this study: 21 from CF patients\' sputum, 20 from non-CF clinical samples and eight from environmental samples ([Table 1](#tbl1){ref-type="table"}). Most of them (*n* = 35) were collected in our laboratory; nine collection strains were purchased from the Institut Pasteur, France, including six type strains, and five were kindly provided by J. J. LiPuma (Department of Pediatrics and Communicable Diseases, University of Michigan Medical School). Isolates were identified at the genus level either by using the conventional biochemical method API 20NE (bioMérieux) or by sequencing the 16S rRNA gene. The identification to the species level was performed by sequencing the 765 bp internal *nrdA* fragment followed by *Achromobacter* PubMLST database query (<http://pubmlst.org/achromobacter/>). Minimal inhibitory concentrations (MICs) of tobramycin, amikacin, gentamicin and netilmicin were measured by the Etest method (bioMérieux). Mueller-Hinton agar plates were inoculated by swabbing from a 0.5 McFarland turbidity bacterial suspension, and MICs were recorded after overnight incubation at 37°C by two persons independently. The phenotype "AG-susceptible" (AG-S) was attributed to isolates susceptible to all AG and the phenotype "AG-resistant" (AG-R) to the other by using the European Committee on Antimicrobial Susceptibility Testing clinical breakpoints for *Pseudomonas* spp. ([http://www.eucast.org/clinical_breakpoints/; version 5.0](http://www.eucast.org/clinical_breakpoints/;%20version%205.0){#interref0010}). Detection of the *axyXY-oprZ* operon was performed by 2 PCRs targeting the genes (a) *axyY,* encoding the RND transporter, and (b) *oprZ,* encoding the outer membrane factor. PCRs were carried out in reaction mixtures containing dNTP (0.2 mM), forward and reverse primers (0.25 μM each), Taq polymerase (Fermentas) (2.5 U) with the supplied buffer, MgCl~2~ (1.5 mM), dimethyl sulfoxide (5% volume) and template DNA (1 μL), adjusted with water to a final volume of 50 μL. The cycling parameters were 94°C for 10 minutes, 30 cycles of 94°C for 90 seconds, annealing primers temperature for 90 sections, 72°C for 60 seconds, and 72°C for 10 minutes. The results are summarized in [Table 1](#tbl1){ref-type="table"}.

The *nrdA* sequences analysis allowed identification of 48 of the 49 isolates. *nrdA* sequence of ACH-CF-583 harboured 39 nucleotide differences, with its closest match in database (genogroup 19) ([Fig. 1](#fig1){ref-type="fig"}) indicating that this isolate belonged to a novel genogroup or a novel species. Fourteen of the 49 studied isolates were categorized as AG-S. Interestingly, all isolates belonging to a same species harboured the same AG resistance pattern. In the resistant species, the level of resistance was sometimes variable among the isolates. Nevertheless, none of these isolates had been categorized as susceptible for all four AG molecules. A variable expression level of the efflux operon might account for these differences as already observed for *Pseudomonas aeruginosa* [@bib16]. Distribution of the AG-S and AG-R isolates according to species identification is represented in a dendrogram ([Fig. 2](#fig2){ref-type="fig"}) generated from the *nrdA* sequences using the neighbour-joining method with 1000 bootstrap replications (MEGA6). We also included in the dendrogram the *nrdA* sequences of the type strains (LMG) of the recently described novel species. AG-S isolates were divided up into two clusters of species including *A. animicus* and *A. mucicolens* (cluster 1), and *A. spanius* and *A. piechaudii* (cluster 2). These two clusters were supported by high bootstrap values. All other isolates were AG-R and did not belong to cluster 1 or 2. They included the 16 *A. xylosoxidans* isolates and all isolates from the species *A. aegrifaciens, A. denitrificans, A. dolens, A.* genogroup 12, *A. insolitus, A. insuavis, A. marplatensis* and *A. ruhlandii.* A similar tree topology was obtained by using the maximum likelihood and the maximum parsimony methods (data not shown). There was a perfect correlation between the AG resistance profile and the presence of the AxyXY-OprZ efflux system. Indeed, the operon was detected in all AG-R isolates and not in the AG-S ones. An additional PCR was performed in all AG-S isolates with primers designed in flanking sequences of the *axyXY-oprZ* operon and confirmed the absence of the whole operon. Because the GC content of the efflux operon is similar to that of whole genome, we hypothesized that a deletion occurred in the course of evolution. These findings indicate that susceptibility or resistance to AG might be a phenotypic trait correlated with *Achromobacter* species evolution.

To date, and to our knowledge, only four studies including an appropriate *Achromobacter* identification method report distribution of the different *Achromobacter* species in clinical samples. They indicate that *A. xylosoxidans* is the species the most frequently recovered from CF patients [@bib11], [@bib17], [@bib18], [@bib19]. Other species are also widely prevalent: *A. ruhlandii, A. dolens* and *A. insuavis.* It is noteworthy that all isolates belonging to these four species have been categorized as AG-R in the present work. One can therefore wonder whether these AG-R species are more pathogenic than the AG-S ones, which might explain their high prevalence. One might also hypothesize that these species have emerged under the selection pressure of AG treatment frequently prescribed to those in the CF population.

In conclusion, AG resistance is the first phenotypic characteristic correlated with the different species of the genus *Achromobacter.* More studies including accurate species level identification are required in order to improve knowledge about the epidemiology and virulence of these pathogens. They might also help to elucidate whether the use of inhaled AG promotes selection of *Achromobacter* that belong to the species harbouring the AxyXY-OprZ efflux system.
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![ACH-CF-583 *nrdA* sequence alignment with its closest match (genogroup 19) in *Achromobacter* PubMLST database. Query: ACH-CF-583; Ref: closest match in database.](gr1){#fig1}

![Neighbour-joining dendrogram based on *nrdA* sequence. Numbers at nodes indicate bootstrap values. Scale bar indicates number of substitutions per site. AG-resistant (AG-R) isolates are in upper box; AG-susceptible (AG-S) isolates are in boxes 'cluster 1' and 'cluster 2.' AG resistance was not determined for the LMG strains.](gr2){#fig2}
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*Achromobacter* isolates and main results

  *nrdA* identification   Isolate       Origin                                                         MIC (mg/L)   AG S/R   PCR *axyY*   PCR *oprZ*            
  ----------------------- ------------- -------------------------------------------------------------- ------------ -------- ------------ ------------ --- ---- ----
  *A. aegrifaciens*       ACH-CF-D59    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    \>256        \>256    \>256        \>256        R   \+   \+
  *A. aegrifaciens*       ACH-CF-802    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    64           48       16           32           R   \+   \+
  *A. aegrifaciens*       ACH-ENV-2     Hospital hand-washing sink[a](#tbl1fna){ref-type="table-fn"}   12           8        3            8            R   \+   \+
  *A. aegrifaciens*       ACH-CF-766    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    192          48       12           64           R   \+   \+
  *A. animicus*           ACH-CF-864    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    1.5          4        1            1            S   −    −
  *A. animicus*           ACH-NCF-33    Catheter[a](#tbl1fna){ref-type="table-fn"}                     1.5          6        2            2            S   −    −
  *A. animicus*           ACH-CF-D63    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    1.5          4        1.5          1            S   −    −
  *A. animicus*           ACH-CF-D64    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    2            8        2            1.5          S   −    −
  *A. animicus*           ACH-CF-D65    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    1            3        1.5          1.5          S   −    −
  *A. animicus*           ACH-CF-711    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    2            4        1.5          1.5          S   −    −
  *A. denitrificans*      CIP-77.15T    Soil                                                           32           256      64           64           R   \+   \+
  *A. dolens*             AU18822       CF sputum                                                      \>256        64       \>256        12           R   \+   \+
  *A. dolens*             AU20310       CF sputum                                                      \>256        \>256    \>256        128          R   \+   \+
  *A.* genogroup 12       ACH-ENV-3     Dialysis water[a](#tbl1fna){ref-type="table-fn"}               3            32       8            8            R   \+   \+
  Novel species           ACH-CF-583    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    24           \>256    96           \>256        R   \+   \+
  *A. insolitus*          CIP-108202T   Leg wound                                                      256          32       48           \>256        R   \+   \+
  *A. insuavis*           ACH-CF-476    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    \>256        \>256    \>256        \>256        R   \+   \+
  *A. insuavis*           ACH-CF-777    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    96           \>256    \>256        \>256        R   \+   \+
  *A. insuavis*           AXX-A         Ear swab[a](#tbl1fna){ref-type="table-fn"}                     16           256      24           64           R   \+   \+
  *A. insuavis*           CIP-102062    Blood                                                          12           256      16           24           R   \+   \+
  *A. marplatensis*       ACH-ENV-4     Lake[a](#tbl1fna){ref-type="table-fn"}                         12           256      24           32           R   \+   \+
  *A. mucicolens*         ACH-NCF-34    Tracheal aspirate[a](#tbl1fna){ref-type="table-fn"}            1.5          6        1.5          1.5          S   −    −
  *A. mucicolens*         ACH-NCF-35    Tracheal aspirate[a](#tbl1fna){ref-type="table-fn"}            2            8        2            1.5          S   −    −
  *A. mucicolens*         ACH-NCF-36    Blood[a](#tbl1fna){ref-type="table-fn"}                        2            6        2            2            S   −    −
  *A. mucicolens*         ACH-CF-510    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    2            8        2            2            S   −    −
  *A. piechaudii*         CIP-60.75T    Pharynx                                                        1.5          6        3            3            S   −    −
  *A. ruhlandii*          CIP-77.26T    Soil                                                           8            24       12           16           R   \+   \+
  *A. ruhlandii*          AU19877       CF sputum                                                      16           \>256    48           64           R   \+   \+
  *A. ruhlandii*          AU19911       CF sputum                                                      3            48       6            12           R   \+   \+
  *A. ruhlandii*          AU19929       CF sputum                                                      \>256        \>256    \>256        \>256        R   \+   \+
  *A. spanius*            CIP-108199T   Blood                                                          1.5          6        4            4            S   −    −
  *A. spanius*            ACH-NCF-37    Foot wound[a](#tbl1fna){ref-type="table-fn"}                   1            4        1            1.5          S   −    −
  *A. spanius*            ACH-CF-746    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    2            6        2            2            S   −    −
  *A. xylosoxidans*       ACH-CF-809    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    128          \>256    256          \>256        R   \+   \+
  *A. xylosoxidans*       ACH-NCF-39    Insertion-site skin swab[a](#tbl1fna){ref-type="table-fn"}     24           \>256    64           128          R   \+   \+
  *A. xylosoxidans*       ACH-NCF-18    Tracheal aspirate[a](#tbl1fna){ref-type="table-fn"}            64           \>256    128          256          R   \+   \+
  *A. xylosoxidans*       CIP-71.32T    Ear discharge                                                  192          \>256    \>256        \>256        R   \+   \+
  *A. xylosoxidans*       CIP-101902    Pleural fluid                                                  \>256        \>256    \>256        \>256        R   \+   \+
  *A. xylosoxidans*       CIP-102236    Sputum                                                         48           \>256    256          \>256        R   \+   \+
  *A. xylosoxidans*       ACH-NCF-41    Sputum[a](#tbl1fna){ref-type="table-fn"}                       32           \>256    64           128          R   \+   \+
  *A. xylosoxidans*       ACH-NCF-42    Tracheal aspirate[a](#tbl1fna){ref-type="table-fn"}            8            256      24           64           R   \+   \+
  *A. xylosoxidans*       ACH-ENV-1     Dental instrument[a](#tbl1fna){ref-type="table-fn"}            192          \>256    \>256        \>256        R   \+   \+
  *A. xylosoxidans*       ACH-NCF-13    Bronchial aspirate[a](#tbl1fna){ref-type="table-fn"}           64           \>256    128          \>256        R   \+   \+
  *A. xylosoxidans*       ACH-CF-805    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    24           \>256    48           192          R   \+   \+
  *A. xylosoxidans*       ACH-NCF-11    Sputum[a](#tbl1fna){ref-type="table-fn"}                       16           256      32           48           R   \+   \+
  *A. xylosoxidans*       ACH-CF-842    CF sputum[a](#tbl1fna){ref-type="table-fn"}                    8            192      24           32           R   \+   \+
  *A. xylosoxidans*       ACH-NCF-40    Blood[a](#tbl1fna){ref-type="table-fn"}                        32           \>256    96           192          R   \+   \+
  *A. xylosoxidans*       ACH-ENV-5     River[a](#tbl1fna){ref-type="table-fn"}                        16           \>256    24           64           R   \+   \+
  *A. xylosoxidans*       ACH-ENV-6     Domestic hand-washing sink[a](#tbl1fna){ref-type="table-fn"}   32           \>256    48           128          R   \+   \+

AG, aminoglycoside; AMK, amikacin; CF, cystic fibrosis; GEN, gentamicin; MIC, minimum inhibitory concentration; NET, netilmicin; R, resistant.; S, susceptible; TOB, tobramycin.

Isolates collected in our laboratory.
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